| Glaxosmithkline Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500660 |
NSE Symbol : GLAXO |
P/E(TTM) : 61.81 |
|
ISIN Demat : INE159A01016 |
Div & Yield% : 1.14 |
EPS(TTM) : 45.22 |
|
Book Value(₹) : 105.31 |
Market Cap(₹Cr) : 47,352.37 |
Face Value(₹) : 10.00 |
| Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | |
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Equity Share Capital | 169.41 | 169.41 | 169.41 | 169.41 | 169.41 |
| Reserves | 1,614.69 | 1,583.59 | 2,508.21 | 1,327.71 | 1,670.63 |
| Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Shareholders Funds | 1,784.10 | 1,753.00 | 2,677.62 | 1,497.12 | 1,840.04 |
| Secured Loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured Loans | 18.67 | 15.54 | 20.08 | 34.63 | 0.18 |
| Total Debt | 18.67 | 15.54 | 20.08 | 34.63 | 0.18 |
| Other Liabilities | 246.30 | 254.22 | 263.00 | 260.29 | 289.39 |
| Total Liabilities | 2,049.07 | 2,022.76 | 2,960.70 | 1,792.04 | 2,129.61 |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 665.51 | 635.93 | 593.89 | 602.89 | 1,454.59 |
| Less: Accumulated Depreciation | 344.26 | 305.99 | 263.26 | 216.00 | 696.53 |
| Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Block | 321.25 | 329.94 | 330.63 | 386.89 | 758.06 |
| Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Work in Progress | 13.93 | 20.31 | 30.50 | 13.21 | 120.12 |
| Investments | 837.72 | 542.78 | 390.09 | 24.49 | 24.49 |
| Current Assets, Loans & Advances | |||||
| Inventories | 514.30 | 437.70 | 512.71 | 523.34 | 483.03 |
| Sundry Debtors | 222.06 | 192.38 | 205.24 | 215.60 | 99.80 |
| Cash and Bank Balance | 1,061.20 | 1,150.73 | 2,479.11 | 1,157.68 | 1,066.41 |
| Loans and Advances | 155.08 | 167.62 | 108.05 | 274.71 | 107.54 |
| Total Current Assets | 1,952.62 | 1,948.43 | 3,305.12 | 2,171.33 | 1,756.78 |
| Less : Current Liabilities and Provisions | |||||
| Current Liabilities | 806.64 | 590.94 | 1,046.53 | 866.70 | 559.87 |
| Provisions | 692.10 | 713.99 | 615.36 | 438.35 | 442.04 |
| Total CL & Provisions | 1,498.74 | 1,304.94 | 1,661.90 | 1,305.05 | 1,001.92 |
| Net Current Assets | 453.88 | 643.49 | 1,643.22 | 866.28 | 754.86 |
| Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Assets | 163.08 | 151.38 | 131.67 | 117.24 | 126.09 |
| Deferred Tax Liability | 17.14 | 18.20 | 18.89 | 15.57 | 17.24 |
| Net Deferred Tax | 145.94 | 133.18 | 112.78 | 101.67 | 108.85 |
| Other Assets | 276.33 | 353.06 | 453.48 | 399.49 | 363.22 |
| Total Assets | 2,049.05 | 2,022.76 | 2,960.70 | 1,792.03 | 2,129.60 |
| Contingent Liabilities | 375.40 | 350.59 | 351.10 | 485.78 | 471.42 |